In 2022, approximately 223 million individuals were living with atopic dermatitis with approximately 43 million of them falling within the age group of 1 to 4 years old.
Eczema, also known as atopic dermatitis, significantly affects around 20% of children and up to 10% of adults, imposing a substantial burden on health and healthcare systems. Atopic dermatitis ranks 15th among non-fatal diseases in disability-adjusted life years, with the highest impact among skin conditions, primarily affecting children.
Eczema, marked by intense itching, skin redness, rash formation, and persistent dryness, profoundly affects comfort and daily life for sufferers.
![eczefolia logo [outlined]](https://nexuswise.com/wp-content/uploads/2023/10/Eczefolia-Logo-Outlined.png "Eczefolia Logo [Outlined]"){kind=logo}
ECZEFOLIAâ„¢: Revolutionizing Eczema Care Naturally and Steroid-Free
The world’s first botanical-enriched extract derived from Melicope Ptelefolia, also known as Tenggek Burung, represents a groundbreaking development in the treatment of eczema. This innovative extract offers a safe and effective alternative to traditional treatments, as it is completely steroid-free.
NutriSealâ„¢ Technology: Elevating Eczema Relief Sustainably and Effectively
The adoption of advanced NutriSealâ„¢ technology ensures that the extract retains the potency and effectiveness of ECZEFOLIAâ„¢, providing reliable relief for individuals struggling with eczema. This development offers a promising and holistic approach to eczema management, embodying a fusion of nature and advanced science.
